Anterix (ATEX) Revenue (2016 - 2025)

Anterix filings provide 13 years of Revenue readings, the most recent being $1.6 million for Q4 2025.

  • On a quarterly basis, Revenue changed 0.45% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.9 million, a 0.51% increase, with the full-year FY2025 number at $6.0 million, up 43.9% from a year prior.
  • Revenue hit $1.6 million in Q4 2025 for Anterix, up from $1.6 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.6 million in Q4 2025 to a low of $181000.0 in Q1 2021.
  • Median Revenue over the past 5 years was $830000.0 (2023), compared with a mean of $897450.0.
  • Biggest five-year swings in Revenue: crashed 44.65% in 2021 and later soared 164.32% in 2023.
  • Anterix's Revenue stood at $385000.0 in 2021, then surged by 50.13% to $578000.0 in 2022, then surged by 119.9% to $1.3 million in 2023, then increased by 23.21% to $1.6 million in 2024, then grew by 0.45% to $1.6 million in 2025.
  • The last three reported values for Revenue were $1.6 million (Q4 2025), $1.6 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.